key: cord-0850193-kyqhiewa
authors: Zhou, J.; Ma, Yi; Liu, Y.; Xiang, Y.; Tao, C.; Yu, H.; Huang, J.
title: A Correlation Analysis Between the Nutritional Status and Prognosis of COVID-19 Patients
date: 2020-08-10
journal: J Nutr Health Aging
DOI: 10.1007/s12603-020-1457-6
sha: d5c529e6e8a89ccdfeebc0d8c73c57721f0a4bd6
doc_id: 850193
cord_uid: kyqhiewa

PURPOSE: The present study investigated the correlation between the nutritional status and prognosis of COVID-19 patients, and analyzed the epidemiological characteristics of COVID-19 patients with different nutritional status. METHODS: 429 patients who were diagnosed positive for COVTD-19 in Hubei Provincial Hospital of Traditional Chinese Medicine from December 2019 to March 2020 were selected and divided into different groups based on Controlling Nutritional Status (CONUT) score (0–4: the low CONUT score group; 5–12: the high CONUT score group). Multivariate logistic regression analysis was applied to investigate the effects of CONUT score on prognosis. RESULTS: The total score of admission status of patients with higher CONUT score was higher than that of those with lower CONUT score (χ(2) = 7.152, P = 0.007). The number of adverse outcomes of female was higher than that of male (χ(2) = 10.253, P = 0.001). The number of adverse outcomes was higher for patients with smoking history (P = 0.004) or hypertension (χ(2) = 11.240, P = 0.001) than those without. Also, the number of adverse outcomes was higher for older patients than younger ones (χ(2) = 15.681, P < 0.001). Patients with adverse outcomes had lower urine red blood cell count than patients without adverse outcomes (χ(2) = 5.029, P = 0.025). However, BMI, drinking history and diabetes did not show correlation with the prognosis of COVID-19 (P > 0.05). Among patients ≥ 61 years old, the risk of adverse outcomes in the high CONUT score group was 6.191 times that of the low CONUT score group (OR = 6.191, 95% CI: 1.431–26.785). Among the non-diabetic patients, the risk of adverse outcomes in the high CONUT group was 11.678 times that of the low CONUT group (OR = 11.678, 95% CI: 2.754–49.41). For the patients who had a total score of admission status < 6, the risk of adverse outcomes in the high CONUT score group was 8.216 times that of the low CONUT score group (OR = 8.216, 95% CI: 2.439–27.682). CONCLUSION: COVID-19 patients with good nutritional status showed a small chance to have adverse outcomes. Gender, age, hypertension, the number of urine red blood cell count and CONUT score affected the adverse outcomes of patients.

value, and patients were divided into the high-score and low-score group. Since serum albumin representing protein reserves, total cholesterol representing energy expenditure and lymphocyte count representing immune defense, a higher score refers to a worse nutritional status of patients. Thus, the CONUT score is used to predict the acute aggravation of surgical patients.

The data was analyzed by SPSS 20.0, and cases with complete clinical data were further selected for statistical analysis. Difference analysis was firstly done on the general data of groups with either high or low CONUT score, and then further difference analysis was done on the adverse outcomes (death, transferring to ICU, heart/respiratory failure). Data with normal distribution was expressed as mean ± standard deviation (Student's t test). Data with skewed distribution was expressed as median and quartile M(Q25,Q75) (Mann-Whitney U test). Classified data was expressed as the number of cases and percentile N (%) (Chi-square test or Fisher's exact test). Graded data was expressed as the number of cases and percentile N (%) (Mann-Whitney U test) . Factors affecting the difference in clinical data between the high CONUT score group and the low CONUT score group were included in the logistic regression analysis of adverse outcomes as covariates in order to investigate the effects of CONUT score on adverse outcomes. P < 0.05 was considered as statistically significant.

Results showed that the proportion of diabetic patients in the high CONUT score group was higher than that in the low CONUT score group (χ 2 = 6.552, P = 0.010). The average age of the high CONUT score group was older than that of the low CONUT score group (χ 2 = 37.128, P < 0.001). The score of admission status of the high CONUT score group was also higher than that of the low CONUT score group (χ 2 = 7.152, P = 0.007). However, gender, BMI, smoking history did not show significant differences between the high and low CONUT score groups (P > 0.05). More detailed information is shown in Table  1 .

Results showed that patients with adverse outcomes had a higher proportion of smoking history than patients without adverse outcomes (P = 0.004). Also, patients with adverse outcomes had a higher proportion of hypertension than patients without adverse outcomes (χ2 = 11.240, P = 0.001). The average age of patients with adverse outcomes was older than that of patients without adverse outcomes (χ2 = 15.681, P < 0.001). Patients with adverse outcomes also showed a lower urine red blood cell count than those without adverse outcomes (χ2 = 5.029, P = 0.025). While, BMI, drinking history and diabetes did not show correlation with the adverse outcomes (P > 0.05). More detailed information is shown in Table 2 .

Multivariate regression analysis of adverse outcomes Gender, age, smoking history, hypertension, coronary heart disease, urinary erythrocytes and other variates in Table 2 were included in the multivariate logistic regression (stepwise progression method). Results showed that gender, age, hypertension and urinary erythrocytes were the key factors affecting adverse outcomes. Detailed information is shown in Table 3 .

According to Table 3 , gender, age, hypertension and urinary erythrocytes were the key variates affecting adverse outcomes. Diabetes, total score of admission status in Table 1 were included in the multivariate logistic regression of adverse outcomes as covariates. Results showed that gender, age, hypertension, urinary erythrocytes and CONUT score were the risky factors affecting adverse outcomes. More detailed information is presented in Table 4 .

The influences of age, diabetes and the total score of admission status on adverse outcomes under different nutritional status were further analyzed, and detailed information is shown in Table 5 .

The COVID-19 virus enters the cell through ACE2 receptor, which mainly locates in type 2 alveolar cells of the lung, upper and esophageal epithelial cells, cardiomyocytes and proximal renal tubules (10) . The major features brought by COVID-19 are acute respiratory disease with diffuse alveolar hemorrhage and acute respiratory failure (11) . However, the virus may enter the bloodstream and accumulate in other organs, such as heart, gastrointestinal tract and kidney, and cause further damage. Serum protein is an important factor of the three standards of CONUT, and also is a reliable index of systematic inflammation (11, 12) . Pro-inflammatory cytokines, such as IL-6 and TNF-α, and CRP can also decrease the concentration of serum albumin and regulate albumin synthesis by liver cells (13, 14) . Low peripheral blood lymphocyte count is an indicator of insufficient host immune response (14) . These three indicators can evaluate the general status of patients comprehensively, and thus we used CONUT score as an indicator to assess the nutritional status of patients. To analyze the predictive effects of CONUT score on adverse outcomes, we assessed the difference in baseline data. The CONUT score ≤ 4 was set as the low CONUT score group, while the CONUT score ≥ 5 was set as the high CONUT score group. Significant differences were observed in three groups of patients in age, diabetes and total score of admission status (Table 1) . Grouped by whether there was any adverse outcome, significant differences were observed in gender, age, smoking history, hypertension and urine red blood cells (Table  2) . After adjusting the influences of many confounding factors, multivariate logistic regression analysis of adverse outcomes was applied and results showed that gender, age, hypertension, urinary red blood cells and CONUT score were the risk factors for adverse outcomes ( Table 3) . Results of Table 4 showed that the risk of adverse outcomes in female patients was 0.332 times that of males, which might be related to hormone levels. The risk of adverse outcomes in older patients was 4.054 times that of younger patients (OR = 4.054, 95% CI: 1.483-11.080). Furthermore, the risk of adverse outcomes in patients with hypertension was 2.900 times that of patients without hypertension (OR = 2.900, 95% CI: 1.246-6.751).The risk of having adverse outcomes in the high CONUT score group was 3.598 times higher than that in the low CONUT score group (OR = 3.598, 95% CI: 1.003-12.902).

Among patients ≥ 61 years old, the risk of adverse outcomes in the high CONUT score group was 6.191 times that of the low CONUT score group (OR = 6.191, 95% CI: 1.431-26.785). However, among patients younger than 61 years old, no statistical difference was observed in the risk of adverse outcomes between the high and the low CONUT groups (P > 0.05). Among the non-diabetic patients, the risk of adverse outcomes in the high CONUT group was 11.678 times that of the low CONUT group (OR = 11.678, 95% CI: 2.754-49.41). While among the diabetic patients, no statistical difference was observed in the risk of adverse outcomes between the high and the low CONUT groups (P > 0.05). For the patients who had a total score of admission status < 6, the risk of adverse outcomes in the high CONUT score group was 8.216 times that of the low CONUT score group (OR = 8.216, 95% CI: 2.439-27.682). However, For the patients who had a total score of admission status ≥ 6, no statistical difference was observed in the risk of adverse outcomes between the high and the low CONUT groups (P > 0.05).

In conclusion, the nutritional status of COVID-19 patients is closely related to clinical outcomes. High CONUT score, male, combined with hypertension or diabetes or advanced age are the risk factors, and patients with these factors have a higher risk of adverse outcomes.

The authors declare that they have no conflict of interest.

Funding source: The study was approved by the Hubei Provincial Hospital of Traditional Chinese Medicine (2020YFC0841600).

Ethical approval: The study was approved by the ethics committee of Hubei Provincial Hospital of Traditional Chinese Medicine (HBZY2020-C14-01). 

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of medicine

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov

The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on singlecell transcriptomes

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China

Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission

The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy

Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Medical science monitor : international medical journal of experimental and clinical research

Rodríguez Salvanés F, Díaz López AM. Nutritional screening; control of clinical undernutrition with analytical parameters

Prognostic nutritional index predicts postoperative outcome in colorectal cancer

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. American journal of kidney diseases : the official journal of the National Kidney Foundation

Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population

Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy

Pre-treatment haemoglobin and peripheral blood lymphocyte count as independent predictors of outcome in carcinoma of cervix

We thank all the participants who were involved in this study and Hubei Provincial Hospital of Traditional Chinese Medicine for providing assistance.